June 27, 2016
Track this case
Freda L. Wolfson
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
A New Jersey federal judge on Thursday pressed the pause button on a pair of proposed shareholder class actions against Celator over its planned $1.5 billion sale to Jazz Pharmaceuticals, after the sides reached a tentative settlement agreement.
Already a subscriber? Click here to login